c-di-GMP was extracted from whole cells as previously described (12). Briefly, the indicated strains were grown overnight in LB or LBCa with antibiotics when appropriate. The next day, cells were diluted 1:100 in fresh medium and grown to an OD600 of 0.5. Cells were again diluted to an OD600 of 0.025 into fresh LB supplemented with the indicated cations and l-Ara where indicated. Cells were grown for 12 h, when peak brp expression was observed in the presence of CaCl2. Six OD units of each sample was centrifuged at 4°C for 10 min at 12,000 × g. The pellet was resuspended in 200 µl of 40% (vol/vol) acetonitrile–40% (vol/vol) methanol–20% 0.1 N formic acid. This suspension was incubated at −20°C for 30 min and then centrifuged at 4°C for 5 min. The supernatant was recovered, and 10 µl of each sample was analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) on a Quattro Premier XE mass spectrometer (Waters) coupled with an Acquity Ultra Performance LC system (Waters). c-di-GMP was detected by electrospray ionization using multiple reaction monitoring in negative-ion mode at m/z 689.16→344.31. The MS parameters were as follows: capillary voltage, 3.5 kV; cone voltage, 50 V; collision energy, 34 V; source temperature, 110°C; desolvation temperature, 350°C; cone gas flow (nitrogen), 50 liters/h; desolvation gas flow (nitrogen), 800 liters/h; collision gas flow (nitrogen), 0.15 ml/min; and multiplier voltage, 650 V. Chromatography separation was reverse phase using a Waters BEH C18 2.1- by 50-mm column at a flow rate of 0.3 ml/min with a gradient of 10 mM tributylamine plus 15 mM acetic acid in 97:3 water-methanol (solution A) to methanol (solution B) with the following parameters: t = 0 min; 99% A:1% B, t = 2.5 min; 80% A:20% B, t = 7.0 min; 35% A:65% B, t = 7.5 min; 5% A:95% B, t = 9.01 min; and 99% A:1% B, t = 10 min. A c-di-GMP standard curve for calculating the c-di-GMP concentration in each extract was generated by dissolving synthesized c-di-GMP (Axxora) in extraction buffer to 250 nM, followed by 2-fold serial dilutions to 0.975 nM. Data from three biological replicates were analyzed for each strain.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.